Aranggo, Jennifer .
HRN: 19-46-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2023
CEFUROXIME 500MG (TAB)
11/23/2023
11/29/2023
ORAL
500mg
BID
Tc Endometritis Sp NSVD Wil Perinal Laceration And Repair
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes